Project Number 2R01NS073502-06 Agency/Funding Organization NINDS Funding Year 2015 View Full Project Details for THERAPEUTIC TARGETING OF ABNORMAL CONFORMATION IN NEURODEGENERATIVE DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator WISNIEWSKI, THOMAS M Principal Investigator First Name THOMAS M Principal Investigator Last Name WISNIEWSKI Awardee Organization NEW YORK UNIVERSITY SCHOOL OF MEDICINE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-302: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $370,781 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CORRIVEAU, RODERICK A Related Resources Repository [AlzPED] Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer’s Disease
